1. Home
  2. Healthcare
  3. global-cancer-diagnostics-market

Global Cancer Diagnostics Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Feb 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
COVID-19 RESOURCESWANT TO KNOW COVID-19 IMPACT ON THIS MARKET?

Global Cancer Diagnostics Market, By Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy, Others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer, Others), End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes, Others) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Cancer Diagnostics Market Cancer Diagnostics Market Analysis and Insights

Cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 6.79% in the above-mentioned forecast period. Rising prevalence of cancer drives the cancer diagnostics market.

Cancer diagnostics is the process of detecting various biomarkers, proteins and certain symptoms that result in the detection of presence of cancerous tumor in the patients. The detection of certain biomarkers and proteins that are prevalent in cancer disorders thereby result in the diagnosis process. The process of detecting cancer includes usage of certain technology and devices specifically used in its diagnosis.

Rising technological advancements is the vital factor escalating the market growth, also increasing initiatives undertaken by governments and global health organizations to spread awareness about cancer, rising growth in the number of private diagnostic centers, rising public-private partnerships to enhance the infrastructure of diagnostic imaging centers, rising Fda support for biomarker development and rising launch of new flow cytometry reagents for diagnostics and drug discovery are the major factors among others driving the cancer diagnostics market. Moreover, rising personalized medicine, increasing development of mass cytometry and the combination of cell-and bead-based flow cytometry technologies, improving healthcare infrastructure in emerging markets and rising miniaturized and technologically advanced devices will further create new opportunities for cancer diagnostics market in the forecasted period of 2021-2028.

However, increasing capital investments & low benefit-cost ratio for biomarkers, rising shortage of helium and rising risk of high radiation exposure likely to limit the usage of CT scanners are the major factors among others which will obstruct the market growth, while rising stringent regulatory guidelines and rising adoption of refurbished diagnostic imaging systems will further challenge the growth of cancer diagnostics market in the forecast period mentioned above.

Cancer diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cancer diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Cancer Diagnostics Market Scope and Market Size

Cancer diagnostics market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, cancer diagnostics market is segmented into imaging testing, biomarkers testing, in vitro diagnostic testing, biopsy and others.

  • Based on application, the cancer diagnostics market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma cancer, prostate cancer, liver cancer and others.

  • The cancer diagnostics market is also segmented on the basis of end-user into diagnostic centers, hospitals and clinics, research institutes and others.

Cancer Diagnostics Market Country Level Analysis

Cancer diagnostics market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above.

The countries covered in the cancer diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the cancer diagnostics market due to rising presence of numerous biotechnology as well as medical device companies, rising greater funding available for research and development projects and high adoption of advanced technologies in this region. Asia-Pacific is the expected region in terms of growth in cancer diagnostics market due to rising favorable government policies supporting the growth of the manufacturing industry, coupled with lower manufacturing costs in this region.

The country section of the cancer diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Cancer diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for cancer diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cancer diagnostics market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Cancer Diagnostics Market Share Analysis

Cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to cancer diagnostics market.

The major players covered in the cancer diagnostics market report are Abbott, Agilent Technologies, Inc., BD, bioMérieux SA, NeoGenomics Laboratories, Inc., Telerad Tech, F. Hoffmann-La Roche Ltd, GENERAL ELECTRIC COMPANY, Hologic Inc., Illumina, Inc., QIAGEN, BioGenex, Siemens Healthcare GmbH, BioNTech Diagnostics GmbH, Thermo Fisher Scientific Inc. and Koninklijke Philips N.V. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global Cancer Diagnostics Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

 

SKU-

LIST OF TABLE : GLOBAL CANCER DIAGNOSTICS MARKET

TABLE 1 GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 2 GLOBAL PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 3 GLOBAL POLYMERASE CHAIN REACTION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 4 GLOBAL IN SITU HYBRIDIZATION MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 5 GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 6 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 7 GLOBAL DNA MICROARRAYS MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 8 GLOBAL FLOW CYTOMETRY MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 9 GLOBAL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY REGION, 2015– 2024 (USD MILLION) TABLE 10 GLOBAL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING BY REGION, 2015– 2024 (USD MILLION) TABLE 11 GLOBAL INSTRUMENT BASED CNACER DIAGNOSTICS MARKET, BY BIOPSY , BY REGION, 2015– 2024 (USD MILLION) TABLE 12 GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION) TABLE 13 WORLDWIDE LUNG CANCER INCIDENCES TABLE 14 GLOBAL CANCER DIAGNOSTICS MARKET, LUNG CANCER, BYREGION, 2015 – 2024 (USD MILLION) TABLE 15 WORLDWIDE BREAST CANCER INCIDENCES TABLE 16 GLOBAL CANCER DIAGNOSTICS MARKET, BY BREAST CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 17 WORLDWIDE COLORECTAL CANCER INCIDENCES TABLE 18 GLOBAL CANCER DIAGNOSTICS MARKET, BY COLORECTAL CANCER, BY REGION, 2015 – 2024 (USD MILLION) TABLE 19 WORLDWIDE MELANOMA CANCER INCIDENCES TABLE 20 GLOBAL CANCER DIAGNOSTICS MARKET, BY MELANOMA , BY REGION2015 – 2024 (USD MILLION) TABLE 21 ESTIMATED NEW CASES OF CANCER IN 2017 TABLE 22 GLOBAL CANCER DIAGNOSTICS MARKET, BY OTHERS, BY REGION, 2015 – 2024 (USD MILLION) TABLE 23 GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015 – 2024 (USD MILLION) TABLE 24 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 25 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 26 NORTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 27 NORTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 28 NORTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 29 NORTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 30 U.S.CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 31 U.S. PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 32 U.S. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 33 U.S. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 34 U.S. CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 35 CANADA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 36 CANADA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 37 CANADA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 38 CANADA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 39 CANADA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 40 MEXICO CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 41 MEXICO PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 42 MEXICO INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 43 MEXICO INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 44 MEXICO CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 45 EUROPE CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024(USD MILLION) TABLE 46 EUROPE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 47 EUROPE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 48 EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 49 EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 50 EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 51 GERMANY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 52 GERMANY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 53 GERMANY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 54 GERMANY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 55 GERMANY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 56 FRANCE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 57 FRANCE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 58 FRANCE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 59 FRANCE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 60 FRANCE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 61 U.K.CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 62 U.K. PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 63 U.K. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 64 U.K. INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 65 U.K. CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 66 ITALY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 67 ITALY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 68 ITALY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 69 ITALY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 70 ITALY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 71 SPAIN CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 72 SPAIN PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 73 SPAIN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 74 SPAIN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 75 SPAIN CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 76 RUSSIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 77 RUSSIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 78 RUSSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 79 RUSSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 80 RUSSIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 81 TURKEY CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 82 TURKEY PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 83 TURKEY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 84 TURKEY INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 85 TURKEY CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 86 BELGIUM CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 87 BELGIUM PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 88 BELGIUM INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 89 BELGIUM INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 90 BELGIUM CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 91 NETHERLANDSCANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 92 NETHERLANDS PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 93 NETHERLANDS INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 94 NETHERLANDS INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 95 NETHERLANDS CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 96 SWITZERLAND CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 97 SWITZERLAND PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 98 SWITZERLAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 99 SWITZERLAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 100 SWITZERLAND CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 101 REST OF EUROPECANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 102 REST OF EUROPE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 103 REST OF EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 104 REST OF EUROPE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 105 REST OF EUROPE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 106 APAC CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 107 APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 108 APAC PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 109 APAC INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 110 APAC INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 111 APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 112 JAPANCANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 113 JAPAN PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 114 JAPAN INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 115 JAPAN INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 116 JAPAN CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 117 CHINA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 118 CHINA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 119 CHINA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 120 CHINA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 121 CHINA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 122 INDIACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 123 INDIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 124 INDIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 125 INDIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 126 INDIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 127 SOUTH KOREA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 128 SOUTH KOREA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 129 SOUTH KOREA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 130 SOUTH KOREA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 131 SOUTH KOREA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 132 AUSTRALIACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 133 AUSTRALIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 134 AUSTRALIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 135 AUSTRALIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 136 AUSTRALIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 137 THAILAND CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 138 THAILAND PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 139 THAILAND INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 140 THAILAND INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 141 THAILAND CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 142 SINGAPORE CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 143 SINGAPORE PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 144 SINGAPORE INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 145 SINGAPORE INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 146 SINGAPORE CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 147 MALAYSIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 148 MALAYSIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 149 MALAYSIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 150 MALAYSIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 151 MALAYSIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 152 INDONESIA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 153 INDONESIA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 154 INDONESIA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 155 INDONESIA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 156 INDONESIA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 157 PHILIPPINES CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 158 PHILLIPINES PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 159 PHILIPPINES INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 160 PHILIPPINES INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 161 PHILIPPINES CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 162 REST OF APAC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 163 REST OF APAC PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 164 REST OF APAC INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 165 REST OF APAC INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 166 REST OF APAC CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 167 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 168 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 169 SOUTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 170 SOUTH AMERICA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 171 SOUTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 172 SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 173 BRAZIL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 174 BRAZIL PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 175 BRAZIL INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 176 BRAZIL INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 177 BRAZIL CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 178 REST OF SOUTH AMERICACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 179 REST OF SOUTH AMERICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 180 REST OF SOUTH AMERICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 181 REST OF SOUTH AMERICA INSTRUMENT BASED IMAGING CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 182 REST OF SOUTH AMERICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 183 MEA CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION) TABLE 184 MEA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 185 MEA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 186 MEA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 187 MEA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 188 MEA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 189 SOUTH AFRICA CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION) TABLE 190 SOUTH AFRICA PLATFORM BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 191 SOUTH AFRICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION) TABLE 192 SOUTH AFRICA INSTRUMENT BASED CANCER DIAGNOSTICS MARKET, BY IMAGING TYPE, 2015 – 2024 (USD MILLION) TABLE 193 SOUTH AFRICA CANCER DIAGNOSTICS MARKET, BY APPLICATION 2015 – 2024 (USD MILLION) TABLE 194 REST OF MEACANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries

Buy Now Add to Cart
Advance Formative Research Customization
Request for bulk
Reports
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Browse Related Reports

North America Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Europe Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Asia-Pacific Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Global Noninvasive Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Global Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Global Breast Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Global Lung Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Global Ovarian Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Global Liver Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Global Next Generation Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Global Adrenal Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Global Thyroid Cancer Diagnostics Market – Industry Trends and Forecast to 2027

Asia-Pacific Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Europe Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Middle East and Africa Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028

North America Prostate Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Global Non-Small Cell Lung Cancer Diagnostics Market – Industry Trends and Forecast to 2028

North America Non-Small Cell Lung Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Europe Non-Small Cell Lung Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Asia-Pacific Non-Small Cell Lung Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Middle East And Africa Non-Small Cell Lung Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Global Gastric Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Asia-Pacific Gastric Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Middle East and Africa Gastric Cancer Diagnostics Market – Industry Trends and Forecast to 2028

North America Gastric Cancer Diagnostics Market – Industry Trends and Forecast to 2028

Europe Gastric Cancer Diagnostics Market – Industry Trends and Forecast to 2028


Browse Related Blogs

Cancer Diagnostics Market to grow at a CAGR of 6.84% in the forecast period of 2019 to 2026 due to increasing cases of cancer worldwide

Global Cancer Diagnostics Market is Poised to Grow at 11.7% till 2024

Global Cancer Diagnostics Market is Expected to Grow at a CAGR of 11.7% in the Forecast Period 2017-2024

Global Cancer Diagnostics Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026

Europe Cancer Diagnostics Market is Expected to Grow at 5.0% in the Forecast Period of 2020 to 2027

Global Noninvasive Cancer Diagnostics Market is Rising Exponentially at a CAGR of 6.90% in the Forecast Period

Global Prostate Cancer Diagnostics Market is Expected to Grow at 20.1% in the Forecast Period of 2021 to 2028

Global Non-Small Cell Lung Cancer Diagnostics Market is Growing With a CAGR Of 13.2% in the Forecast Period of 2021 to 2028

Global Gastric Cancer Diagnostics Market is Growing with a CAGR of 6.8% in the Forecast Period of 2021 to 2028

North America Non-Small Cell Lung Cancer Diagnostics Market is Growing with a CAGR of 13.0% in the Forecast Period of 2021 to 2028


Browse Related Infographics

Europe Cancer Diagnostics Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2027


REPORTS

MARKET INSIGHT

SUPPORT

SOLUTIONS

DMCA Protected © DataBridge - All Rights Reserved.